Your browser doesn't support javascript.
loading
Loss of CXCR4 in Myeloid Cells Enhances Antitumor Immunity and Reduces Melanoma Growth through NK Cell and FASL Mechanisms.
Yang, Jinming; Kumar, Amrendra; Vilgelm, Anna E; Chen, Sheau-Chiann; Ayers, Gregory D; Novitskiy, Sergey V; Joyce, Sebastian; Richmond, Ann.
Affiliation
  • Yang J; Tennessee Valley Healthcare System, Department of Veterans Affairs, Vanderbilt University Medical Center, Nashville, Tennessee.
  • Kumar A; Department of Pharmacology, Vanderbilt University Medical Center, Nashville, Tennessee.
  • Vilgelm AE; Tennessee Valley Healthcare System, Department of Veterans Affairs, Vanderbilt University Medical Center, Nashville, Tennessee.
  • Chen SC; Department of Pathology, Microbiology and Immunology, Vanderbilt University Medical Center, Nashville, Tennessee.
  • Ayers GD; Department of Pharmacology, Vanderbilt University Medical Center, Nashville, Tennessee.
  • Novitskiy SV; Department of Biostatistics, Vanderbilt University Medical Center, Nashville, Tennessee.
  • Joyce S; Department of Biostatistics, Vanderbilt University Medical Center, Nashville, Tennessee.
  • Richmond A; Division of Cancer Biostatistics, Department of Biostatistics, Vanderbilt University, Nashville, Tennessee.
Cancer Immunol Res ; 6(10): 1186-1198, 2018 10.
Article in En | MEDLINE | ID: mdl-30108045
Subject(s)
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Melanoma, Experimental / Killer Cells, Natural / Receptors, CXCR4 / Cytotoxicity, Immunologic / Fas Ligand Protein Type of study: Prognostic_studies Limits: Animals Language: En Journal: Cancer Immunol Res Year: 2018 Document type: Article
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Melanoma, Experimental / Killer Cells, Natural / Receptors, CXCR4 / Cytotoxicity, Immunologic / Fas Ligand Protein Type of study: Prognostic_studies Limits: Animals Language: En Journal: Cancer Immunol Res Year: 2018 Document type: Article